Immunotherapy of melanoma: the good news, the bad ones and what to do next

被引:17
作者
Marincola, FM
Ferrone, S
机构
[1] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
[2] NIH, Immunogenet Sect, Dept Transfus Med, Bethesda, MD 20892 USA
关键词
D O I
10.1016/j.semcancer.2003.09.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:387 / 389
页数:3
相关论文
共 17 条
[1]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[2]  
Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514
[3]   Cancer immunoediting: from immunosurveillance to tumor escape [J].
Dunn, GP ;
Bruce, AT ;
Ikeda, H ;
Old, LJ ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2002, 3 (11) :991-998
[4]   Gene polymorphisms, inflammatory diseases and cancer [J].
Howell, WM ;
Calder, PC ;
Grimble, RF .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2002, 61 (04) :447-456
[5]   Molecular and functional profiling of memory CD8 T cell differentiation [J].
Kaech, SM ;
Hemby, S ;
Kersh, E ;
Ahmed, R .
CELL, 2002, 111 (06) :837-851
[6]   Natural selection of tumor variants in the generation of "tumor escape" phenotypes [J].
Khong, HT ;
Restifo, NP .
NATURE IMMUNOLOGY, 2002, 3 (11) :999-1005
[7]   Genetic instabilities in human cancers [J].
Lengauer, C ;
Kinzler, KW ;
Vogelstein, B .
NATURE, 1998, 396 (6712) :643-649
[8]  
Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6
[9]   Tumors as elusive targets of T-cell-based active immunotherapy [J].
Marincola, FM ;
Wang, E ;
Herlyn, M ;
Seliger, B ;
Ferrone, S .
TRENDS IN IMMUNOLOGY, 2003, 24 (06) :335-342
[10]   Translational Medicine: A two-way road [J].
Francesco M Marincola .
Journal of Translational Medicine, 1 (1)